A recent medical study, conducted by researchers from Massachusetts Hospital, showed that a rare version of the apolipoprotein E (APOE) gene succeeded in helping people resist Alzheimers disease and delaying cognitive decline by about 5 years, according to the American newspaper Washington Post. Joseph Arboleda-Velasquez, MD, PhD, an associate scientist at Mass Eye and Ear, and a co-senior author of the study, study said that finding 27 people, some of whom live in the city and some of whom live in rural areas who carry a genetic risk for Alzheimer's disease, along with the presence of one copy of the Christchurch variant in their genes, which delays cognitive decline by about 5 years, increases the team's confidence in the discovery, and shows that the results could be replicable. Source: Qatar News Agency
Related Posts
AIPU Commends Qatar’s Efforts to Reach Ceasefire in Gaza
Algiers, The Arab Inter-parliamentary Union (AIPU) commended Qatar’s efforts to reach a ceasefire in Gaza and its role in providing humanitarian and relief aid to the region.
This came in the “Algeria Declaration” issued at the conclusion of the unio…
Seizing Israeli telecom cards banned from circulation in Tulkarm
Ramallah – Ma’an – Based on information from the joint operations of the National Security Apparatus: The Customs Control Service seized, this Friday evening in Tulkarm, a vehicle containing 175 Israeli SIM cards that are prohibited from circulation a…
Iraqi resistance targets an Israeli position in occupied Palestinian territories
Baghdad, Iraqi resistance targeted an Israeli enemy site in Umm al-Rashrash in the occupied Palestinian territories.
‘As a part of resisting the occupation and supporting people in Gaza Strip, the Iraqi resistance fighters targeted, with drones, a si…